We are looking forward to another year of progress and accomplishments at AiViva as we continue to work toward our mission of addressing unmet medical needs with our innovative solutions. The year of 2020 has been challenging for all. As we reflect back, we have reason to celebrate this holiday season. AiViva completed our first clinical trial in dermal scarring and wound healing with positive results and initiated a trial in nonmelanoma skin cancer. We look forward with great optimism to a new year to bring us closer to helping patients.
We hope 2021 will bring success for all those working to advance medical treatments to improve patient care and quality of life. Let 2021 be a year of new discoveries, innovations, and improved medicines for patients.
Wishing you all good health and a great year ahead!
AiViva targets specialty therapeutic areas where there is a clear unmet medical need, and where our innovative products would provide a solution to reduce the treatment burden for both patients and physicians
Our proprietary JEL™ Technology is customizable to achieve optimal duration of drug effect ranging from weeks to months allowing us to create novel formulations and explore new clinical uses for drugs